Page last updated: 2024-08-25

methotrexate and Graves Ophthalmopathy

methotrexate has been researched along with Graves Ophthalmopathy in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
El Essawy, RA; Elessawy, KB; Nasr, HE; Swaify, IY1
Aghazadeh, H; Rubinov, A; Weis, E; Zommer, H1
David, J; Insull, EA; Keren, S; Norris, JH; Sipkova, Z; Turner, HE1
Genere, N; Stan, MN1
Murthy, R; Roos, JCP1
Andrei, S; Enache, V; Renetti, A; Spiroiu, C; Zemba, M; Zugravu, V1

Reviews

2 review(s) available for methotrexate and Graves Ophthalmopathy

ArticleYear
Current and Emerging Treatment Strategies for Graves' Orbitopathy.
    Drugs, 2019, Volume: 79, Issue:2

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cyclosporine; Glucocorticoids; Graves Ophthalmopathy; Humans; Immunotherapy; Methotrexate; Mycophenolic Acid; Rituximab; Selenium; Severity of Illness Index

2019
Update on the clinical assessment and management of thyroid eye disease.
    Current opinion in ophthalmology, 2019, Volume: 30, Issue:5

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Decompression, Surgical; Graves Ophthalmopathy; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Sirolimus

2019

Trials

1 trial(s) available for methotrexate and Graves Ophthalmopathy

ArticleYear
Periocular methotrexate versus periocular triamcinolone injections for active thyroid-associated orbitopathy: a randomized clinical trial.
    Japanese journal of ophthalmology, 2023, Volume: 67, Issue:6

    Topics: Exophthalmos; Graves Ophthalmopathy; Humans; Injections, Intraocular; Methotrexate; Prospective Studies; Treatment Outcome; Triamcinolone

2023

Other Studies

3 other study(ies) available for methotrexate and Graves Ophthalmopathy

ArticleYear
Role of methotrexate in thyroid-related orbitopathy.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2018, Volume: 53, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glucocorticoids; Graves Ophthalmopathy; Humans; Injections, Intravenous; Male; Methotrexate; Middle Aged; Retrospective Studies; Time Factors; Treatment Outcome

2018
Early use of steroid-sparing agents in the inactivation of moderate-to-severe active thyroid eye disease: a step-down approach.
    Clinical endocrinology, 2018, Volume: 89, Issue:6

    Topics: Abortifacient Agents, Nonsteroidal; Adult; Aged; Aged, 80 and over; Female; Graves Ophthalmopathy; Humans; Male; Methotrexate; Methylprednisolone; Middle Aged; Retrospective Studies

2018
[Treatment of thyroid ophthalmopathy--a clinical case].
    Oftalmologia (Bucharest, Romania : 1990), 2007, Volume: 51, Issue:1

    Topics: Cyclosporine; Diagnosis, Differential; Drug Therapy, Combination; Glucocorticoids; Graves Ophthalmopathy; Humans; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Middle Aged; Nicergoline; Optic Nerve Diseases; Risk Factors; Smoking; Treatment Outcome; Vasodilator Agents; Visual Field Tests; Vitamin B Complex

2007